There are three reasons that affect the efficacy of pre-emergence herbicides in corn: First, soil moisture is small when the pesticide is used, that is, drought. The principle of weeding with closed herbicides is that the grass seeds that are distributed on the ground surface rapidly germinate after encountering suitable humidity and temperature, and contact or absorb herbicide poisoning during its germination. Therefore, the first condition for the efficacy of closed herbicides is that the soil should have a certain humidity. In the spring sowing of corn in spring sowing, it is often arid and the weeding effect is relatively poor. The second reason is that the summer sowing of maize is because the wheat bran is thicker than the wheat, so it is difficult for the liquid medicine to directly cover the surface to make grass seeds contact and absorb, and the medicinal effect will not be good. Third, the amount of sprayed liquid is small, and it is difficult to evenly cover the surface. More and more people do not want to spray 3 barrels of water per acre and spray only 1 barrel of water. This will not guarantee that the liquid medicine will evenly cover the surface of the earth and it will be difficult to achieve good results. In view of this situation, it is recommended that the application of pesticides before seedlings for post-emergence application should be improved.
Ziprasidone Intermediates
Ziprasidone Intermediates
Ziprasidone is a medication of the atypical antipsychotic type. It is used for the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder. Its intramuscular injection form is approved for acute agitation in people with schizophrenia. Ziprasidone is also used off-label for depression, bipolar maintenance, and posttraumatic stress disorder.
Ziprazidone is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder. Its intramuscular injection form is approved for acute agitation in schizophrenic patients for whom treatment with just ziprasidone is appropriate.
We produce a series of complete intermediates for Ziprasidone, intermediate I (CAS No. 2634-33-5) and intermediate II (CAS No. 7716-66-7) etc.
All of our products are with stable production and strict quality control, making sure your experience with Sunshine Biotech is always enriching, satisfying and fulfilling.
Ziprasidone Intermediates,Cas 7716-66-7,Cas 2634-33-5,Ziprasidone Hydrochloride Intermediate
Nanjing Sunshine Biotech Co., Ltd , https://www.sunshine-bio.com